Schedule 13D ownership disclosure
AURIS MED HLDG AG
Security class unavailable · CUSIP: H0381L104
Event date: 2018-02-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-021829
- Form type
- SC 13D
- Filer
- Altamira Therapeutics Ltd.
- CIK
- CIK 1601936
- Filed
- Apr 23, 2018
- Reporting period
- Feb 28, 2018
- Description
- Schedule 13D beneficial ownership